DE69921682D1 - T.d.polio vielwertiger impstoff gegen mindestens diphterie, poliomyelitis und tetanus - Google Patents

T.d.polio vielwertiger impstoff gegen mindestens diphterie, poliomyelitis und tetanus

Info

Publication number
DE69921682D1
DE69921682D1 DE69921682T DE69921682T DE69921682D1 DE 69921682 D1 DE69921682 D1 DE 69921682D1 DE 69921682 T DE69921682 T DE 69921682T DE 69921682 T DE69921682 T DE 69921682T DE 69921682 D1 DE69921682 D1 DE 69921682D1
Authority
DE
Germany
Prior art keywords
vaccine
diphteria
poliomyelitis
polio
tetanus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69921682T
Other languages
English (en)
Other versions
DE69921682T2 (de
Inventor
Rene Cartier
Patrick Laroche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur MSD SNC
Original Assignee
Pasteur Merieux MSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69921682(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux MSD filed Critical Pasteur Merieux MSD
Application granted granted Critical
Publication of DE69921682D1 publication Critical patent/DE69921682D1/de
Publication of DE69921682T2 publication Critical patent/DE69921682T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69921682T 1998-11-26 1999-11-25 T.d.polio vielwertiger impstoff gegen mindestens diphterie, poliomyelitis und tetanus Revoked DE69921682T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98122373A EP1004314A1 (de) 1998-11-26 1998-11-26 T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population
EP98122373 1998-11-26
PCT/FR1999/002913 WO2000030678A1 (fr) 1998-11-26 1999-11-25 Vaccin t.d.polio multivalent contre au moins la diphterie, la poliomyelite et le tetanos

Publications (2)

Publication Number Publication Date
DE69921682D1 true DE69921682D1 (de) 2004-12-09
DE69921682T2 DE69921682T2 (de) 2005-11-03

Family

ID=8233032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921682T Revoked DE69921682T2 (de) 1998-11-26 1999-11-25 T.d.polio vielwertiger impstoff gegen mindestens diphterie, poliomyelitis und tetanus

Country Status (14)

Country Link
EP (2) EP1004314A1 (de)
JP (1) JP2003525858A (de)
AT (1) ATE281176T1 (de)
AU (1) AU759221B2 (de)
CA (1) CA2352617A1 (de)
CZ (1) CZ20011860A3 (de)
DE (1) DE69921682T2 (de)
DK (1) DK1131094T3 (de)
ES (1) ES2228175T3 (de)
NZ (1) NZ511933A (de)
PL (1) PL347719A1 (de)
PT (1) PT1131094E (de)
WO (1) WO2000030678A1 (de)
ZA (1) ZA200103634B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
AU2007293672B2 (en) 2006-09-07 2013-06-27 Glaxosmithkline Biologicals S.A. Vaccine
CN111032078A (zh) 2017-07-18 2020-04-17 血清研究所印度私人有限公司 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法
JOP20190242A1 (ar) 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL187935B1 (pl) * 1996-07-02 2004-11-30 Connaught Lab Multiwalentna kompozycja immunogenna i jej zastosowanie
GB9623233D0 (en) * 1996-11-07 1997-01-08 Smithkline Beecham Biolog Vaccine composition
BR9714980A (pt) * 1997-09-15 2001-11-06 Pasteur Merieux Msd Vacinas multivalentes
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
AU1390100A (en) 2000-06-13
EP1131094B1 (de) 2004-11-03
PL347719A1 (en) 2002-04-22
ES2228175T3 (es) 2005-04-01
DK1131094T3 (da) 2005-02-14
CA2352617A1 (en) 2000-06-02
NZ511933A (en) 2002-09-27
AU759221B2 (en) 2003-04-10
ATE281176T1 (de) 2004-11-15
PT1131094E (pt) 2005-02-28
WO2000030678A1 (fr) 2000-06-02
JP2003525858A (ja) 2003-09-02
DE69921682T2 (de) 2005-11-03
ZA200103634B (en) 2002-05-06
CZ20011860A3 (cs) 2002-01-16
EP1131094A1 (de) 2001-09-12
EP1004314A1 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
ES2485940T3 (es) Combinación de vacunas contra Meningitis B/C
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
EA200201240A1 (ru) Поливалентная вакцинная композиция
FI934223A0 (fi) Heterocykliscykliska aminderivat
CY1106206T1 (el) Φαρμακευτικη συνθεση πepιεχουσα φενοφιβρατη και μεθοδος παρασκευης της
ATE181551T1 (de) Taxol-derivate
DK0773785T3 (da) Behandling af cancer ced hjælp af HSV-mutant
FR2663130B1 (fr) Dispositif d'exposition par projection.
DK0939648T3 (da) Rotavirusvaccineformuleringer
DE69921682D1 (de) T.d.polio vielwertiger impstoff gegen mindestens diphterie, poliomyelitis und tetanus
TR200001288T2 (tr) Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler.
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
ATE201972T1 (de) Bilderaufhängesystem
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
DK0679378T3 (da) Apparatur til forhindring af snorken
DE60118456D1 (de) Pestivirus Mutanten und dessen enthaltende Impfstoffe
ATE363883T1 (de) Gehhilfe
ATE195427T1 (de) Pertussistoxin enthaltender influenzaimpfstoff
NO983580L (no) 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav
ATE203787T1 (de) Elastische schienenklammern
DE602004018578D1 (de) Rohrabhängung
RU92014469A (ru) Средство для определения степени аттенуации вируса полиомиелита
ES2092511T3 (es) Un metodo para preparar derivados de piridazinona.
BR0103731A (pt) Dispositivo para guarda organizada de álbuns fotográficos
BR8001287U (pt) Disposição introduzida em elemento de sustentação de piso elevado

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8331 Complete revocation